Skip to Content
Merck
CN

P6949

Potassium antimony(III) tartrate hydrate

99% (titration)

Synonym(s):

Antimony potassium tartrate

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C8H4K2O12Sb2 · xH2O
CAS Number:
331753-56-1
Molecular Weight:
613.83 (anhydrous basis)
UNSPSC Code:
12352005
PubChem Substance ID:
24898807
MDL number:
MFCD00149437

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI

1S/2C4H4O6.2K.H2O.2Sb/c2*5-1(3(7)8)2(6)4(9)10;;;;;/h2*1-2H,(H,7,8)(H,9,10);;;1H2;;/q2*-2;2*+1;;2*+3/p-4

SMILES string

O.[K+].[K+].O=C1O[Sb-]23OC1C4O[Sb-]5(OC(C(O2)C(=O)O3)C(=O)O5)OC4=O

InChI key

BBUFTTIHMIIQLI-UHFFFAOYSA-J

assay

99% (titration)

density

2.6 g/mL at 25 °C (lit.)

Looking for similar products? Visit Product Comparison Guide

Other Notes

This product has been replaced by 244791-ALDRICH | Potassium antimony(III) tartrate hydrate ≥99%

pictograms

Skull and crossbonesEnvironment
GHS06,GHS09

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Acute Tox. 4 Inhalation - Aquatic Chronic 2

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
077K3672
086K3703
026K3730
118H3439
102K3662

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Raquel Inocêncio da Luz et al.
Antimicrobial agents and chemotherapy, 53(12), 5197-5203 (2009-09-16)
Diagnostic material from patients with leishmaniasis is generally available as promastigotes, and proper testing for susceptibility to first-line drugs by the intracellular amastigote assay is frequently hampered by the poor infectivity of the promastigotes for the macrophage host cell. Several
T M-H Nguyen et al.
International journal of pharmaceutics, 482(1-2), 21-26 (2014-12-03)
Hyperphosphatemia is one of the main risk factors contributing to morbidity and mortality in patients with end stage renal disease. The demand for a new phosphate binder is continuously increasing since the number of patients suffering under hyperphosphatemia is growing.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service